Related Experiment Video
Updated: Jan 28, 2026

Author Spotlight: Enhancing Diagnostic Strategies and Biomarker Development for Comprehensive Lung Function Analysis
Published on: August 9, 2024
Diffuse parenchymal lung disease caused by surfactant deficiency: dramatic improvement by azithromycin
Guillaume Thouvenin1, Nadia Nathan, Ralph Epaud
1Département de Pneumologie Pédiatrique, Hôpital Armand Trousseau, AP-HP, Université Pierre et Marie Curie-Paris 6, Inserm UMR S-U938, Paris, France. guillaume.thouvenin@trs.aphp.fr
Low-dose azithromycin (AZM) offers a promising, side-effect-free treatment for children with diffuse parenchymal lung disease (DPLD) caused by ABCA3 gene mutations. This finding challenges current treatment limitations and opens new therapeutic avenues for rare lung diseases.
Area of Science:
- Pulmonary Medicine
- Genetics
- Pharmacology
Background:
- Mutations in the ABCA3 gene cause pulmonary surfactant deficiency, leading to diffuse parenchymal lung disease (DPLD) in children.
- Current treatments, primarily systemic steroids, have limited efficacy in managing pediatric DPLD.
Observation:
- A case study of a young boy with ABCA3-related DPLD demonstrated significant and sustained respiratory improvement.
- The patient received low-dose azithromycin (AZM) for six years without experiencing any adverse side effects.
Findings:
- Low-dose azithromycin (AZM) appears to be a highly effective and safe long-term treatment for this specific type of pediatric DPLD.
- Ongoing cellular and molecular studies aim to elucidate the mechanisms behind AZM's therapeutic effects.
Implications:
- This case suggests azithromycin (AZM) as a potential novel therapeutic strategy for children with ABCA3-related DPLD.
- Initiated clinical studies on AZM for various pediatric DPLD forms may expand treatment options for rare lung diseases.
Related Concept Videos
Diffusion
Diffusion
Lung Capacity
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion
Protein Diffusion in the Membrane

